- Home
- ATRC vs ECAT Comparison
ATRC vs ECAT Comparison
Compare ATRC & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- ECAT
- Stock Information
- Founded
- ATRC 2000
- ECAT 2021
- Country
- ATRC United States
- ECAT United States
- Employees
- ATRC N/A
- ECAT N/A
- Industry
- ATRC Medical/Dental Instruments
- ECAT Trusts Except Educational Religious and Charitable
- Sector
- ATRC Health Care
- ECAT Finance
- Exchange
- ATRC Nasdaq
- ECAT Nasdaq
- Market Cap
- ATRC 1.6B
- ECAT 1.7B
- IPO Year
- ATRC 2005
- ECAT N/A
- Fundamental
- Price
- ATRC $32.96
- ECAT $15.50
- Analyst Decision
- ATRC Strong Buy
- ECAT
- Analyst Count
- ATRC 10
- ECAT 0
- Target Price
- ATRC $48.50
- ECAT N/A
- AVG Volume (30 Days)
- ATRC 639.5K
- ECAT 278.6K
- Earning Date
- ATRC 04-30-2025
- ECAT 01-01-0001
- Dividend Yield
- ATRC N/A
- ECAT 9.20%
- EPS Growth
- ATRC N/A
- ECAT N/A
- EPS
- ATRC N/A
- ECAT 2.39
- Revenue
- ATRC $465,307,000.00
- ECAT N/A
- Revenue This Year
- ATRC $14.60
- ECAT N/A
- Revenue Next Year
- ATRC $12.58
- ECAT N/A
- P/E Ratio
- ATRC N/A
- ECAT $7.15
- Revenue Growth
- ATRC 16.55
- ECAT N/A
- 52 Week Low
- ATRC $18.94
- ECAT $14.02
- 52 Week High
- ATRC $43.11
- ECAT $17.30
- Technical
- Relative Strength Index (RSI)
- ATRC 42.27
- ECAT 31.26
- Support Level
- ATRC $31.02
- ECAT $15.26
- Resistance Level
- ATRC $34.30
- ECAT $16.06
- Average True Range (ATR)
- ATRC 1.74
- ECAT 0.25
- MACD
- ATRC 0.07
- ECAT -0.04
- Stochastic Oscillator
- ATRC 42.08
- ECAT 21.33
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.